Comparison
3 Methylglutaconic Aciduria Type 2 C0574083 vs 3 4 Toe Cutaneous Syndactyly C5937396
Clinical comparison between 3 Methylglutaconic Aciduria Type 2 and 3 4 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria Type 2 C0574083
Also called Barth syndrome, this genetic condition primarily affects males and impairs mitochondrial function. It causes heart muscle weakness, muscle weakness, and recurrent infections. Treatment includes cardiac care, infection prevention, and supportive therapies.
3 4 Toe Cutaneous Syndactyly C5937396
Skin webbing between the third and fourth toes, typically present at birth. Usually harmless and often left untreated unless it causes problems.
6 comparison axes
Onset
3 Methylglutaconic Aciduria Type 2 C0574083
0-5
3 4 Toe Cutaneous Syndactyly C5937396
0-0
Onset patterns differ
Severity
3 Methylglutaconic Aciduria Type 2 C0574083
severe
3 4 Toe Cutaneous Syndactyly C5937396
mild
Different severity levels
Chronic
3 Methylglutaconic Aciduria Type 2 C0574083
Chronic
3 4 Toe Cutaneous Syndactyly C5937396
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria Type 2 C0574083
No
3 4 Toe Cutaneous Syndactyly C5937396
No
Different transmission
Body System
3 Methylglutaconic Aciduria Type 2 C0574083
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
musculoskeletal
Same/different system
Category
3 Methylglutaconic Aciduria Type 2 C0574083
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
other
Different category
Bottom line
3-methylglutaconic-aciduria-type-2-C0574083 and 3-4-toe-cutaneous-syndactyly-C5937396 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria Type 2 C0574083 | 3 4 Toe Cutaneous Syndactyly C5937396 | Discriminating power |
|---|---|---|---|
| Heart and muscle involvement | May include cardiomyopathy, low muscle tone, or weakness; not every feature is required. | No expected cardiac or systemic muscle disease from the toe finding alone. | High |
| Infection tendency | Recurrent infections may occur, often linked to low neutrophils, but confirmation is clinical. | No infection predisposition is expected from isolated toe webbing. | High |
| Toe appearance | Toe webbing is not a defining feature. | Skin connection between the third and fourth toes is present from birth. | High |
When to favor each condition
Choose 3 Methylglutaconic Aciduria Type 2 C0574083 when
Male infant or child with cardiomyopathy and weakness
This combination raises concern for Barth syndrome and warrants specialist evaluation.
High
Unexplained recurrent infections with metabolic clues
Neutropenia and organic-acid abnormalities may support further testing.
Moderate
Family history suggesting X-linked inheritance
A compatible pedigree can guide genetic assessment, but does not prove the diagnosis.
Moderate
Choose 3 4 Toe Cutaneous Syndactyly C5937396 when
Isolated skin webbing of toes 3 and 4
A localized congenital finding without systemic features fits cutaneous syndactyly.
High
Normal growth, heart, muscle, and infection history
Absence of systemic disease makes a severe metabolic disorder unlikely.
Moderate
Cosmetic or footwear concern only
Management, if any, is usually local rather than metabolic.
High
How key tests differ
| Test | 3 Methylglutaconic Aciduria Type 2 C0574083 | 3 4 Toe Cutaneous Syndactyly C5937396 | Interpretation |
|---|---|---|---|
| Urine organic acids | 3-methylglutaconic acid elevation may be reported, but a cutoff is not established here. | No metabolic abnormality is expected. | An abnormal result supports, but does not alone diagnose, Barth syndrome. |
| Cardiac evaluation | Echocardiography may show cardiomyopathy or ventricular dysfunction. | Cardiac testing is not indicated by isolated toe webbing. | Heart findings require clinician correlation with genetics and laboratory results. |
| Foot examination or imaging | No characteristic toe abnormality is expected. | Examination shows skin-only webbing; imaging may exclude bone fusion if uncertain. | Imaging distinguishes cutaneous from bony syndactyly but does not assess metabolic disease. |
Prognosis comparison
3 Methylglutaconic Aciduria Type 2 C0574083
- Outcome
- Variable and potentially serious, with outcomes depending on cardiac, infection, and growth complications.
- Factors
- Cardiomyopathy severity, neutropenia, nutrition, and access to specialist care.
3 4 Toe Cutaneous Syndactyly C5937396
- Outcome
- Generally excellent, with little or no long-term health effect.
- Factors
- Whether webbing affects comfort, footwear, hygiene, or includes bone involvement.
Time frame: Barth syndrome requires lifelong monitoring; toe syndactyly is evident at birth and usually stable.
Exact survival and complication rates are not established by this comparison.
Complications comparison
| Complication | Presentation |
|---|---|
| Heart failure or arrhythmia | Possible and potentially serious; monitoring is individualized. Not expected from this toe anomaly. Cardiac risk is a major reason for specialist follow-up in Barth syndrome. |
| Serious infection | May occur with neutropenia, although frequency varies. No increased infection risk is established. Fever in suspected Barth syndrome needs prompt clinical assessment. |
| Functional foot limitation | Not a typical complication. Usually minimal; footwear irritation or cosmetic concern may occur. Treatment is optional unless function, hygiene, or comfort is affected. |
Patient education highlights
- HighDifferent conditions
One is a potentially serious genetic metabolic disorder; the other is usually a harmless toe-skin connection.
- HighWhen to seek care
Poor feeding, breathing difficulty, fainting, marked weakness, or fever in suspected Barth syndrome needs urgent care.
- MediumToe webbing care
Most 3-4 toe webs need no treatment; discuss surgery only for function, hygiene, or significant discomfort.